Skip to content

US · THC · MEDICAL - CARE FACILITIES

Tenet Healthcare Corporation (THC) intrinsic value and stock valuation

$263.19as of 2026-11-21 · Mkt cap 21.11B

Data updated · price as of 2026-11-21

UndervaluedIC value is 20–50% above the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Tenet Healthcare Corporation DCF and intrinsic value

InvestorsCraft values THC with the Chepakovich two-stage DCF model — currently rated undervalued. How the model works · Run your own DCF prefilled from THC’s statements →

Tenet Healthcare Corporation Graham Number

Graham Number: $186.96d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Healthcare · Medical - Care Facilities Dallas, TX 75254 tenethealth.com

How the business is doing

Fiscal 2011–2025, USD

Revenue
$21.3B+3.9% 5y CAGRd
20112025
Net income
$1.41B+28.7% 5y CAGRd
20112025
Free cash flow
$2.53B-2.5% 5y CAGRd
20112025
Total equity
$8.97B+25.4% 5y CAGRd
20112025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2011–2025, USD
20252024202320222021
Revenue$21.3B$20.7B$20.5B$19.2B$19.5B
Operating income$3.44B$5.96B$2.51B$2.33B$2.87B
Net income$1.41B$3.2B$611M$411M$914M
EPSd$15.5M$32.7M$5.83M$3.72M$8.42M
Operating cash flow$3.54B$2.05B$2.37B$1.08B$1.57B
Capital expenditure-$-1.01B-$-931M-$-751M-$-762M-$-658M
Free cash flow$2.53B$1.12B$1.62B$321M$910M
Total assets$29.7B$28.9B$28.3B$27.2B$27.6B
Total debt$13.2B$14.3B$15B$15.1B$15.6B
Net debt$10.3B$11.3B$13.8B$14.2B$13.3B
Total equity$8.97B$8.55B$5.51B$4.61B$4.26B
Cash and short-term investments$2.88B$3.02B$1.23B$858M$2.36B
Income statement
20252024202320222021
Revenue$21.3B$20.7B$20.5B$19.2B$19.5B
Cost of revenue$3.78B$12.5B$12.7B$12.1B$12.2B
Gross profit$17.5B$8.21B$7.81B$7.05B$7.27B
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$8.71B$8.8B$418M$412M$412M
Other expenses$5.39B-$-6.55B$4.88B$4.3B$3.99B
Operating expenses$14.1B$2.25B$5.3B$4.72B$4.4B
Cost and expenses$17.9B$14.7B$18B$16.8B$16.6B
Interest income$0.00$0.00$0.00$0.00$0.00
Interest expense$821M$826M$901M$890M$923M
Depreciation and amortization$863M$818M$870M$841M$855M
Ebitda$4.48B$6.89B$3.39B$3.08B$3.67B
Operating income$3.44B$5.96B$2.51B$2.33B$2.87B
Total other income/expenses, net-$-639M-$-708M-$-893M-$-988M-$-983M
Income before tax$2.8B$5.25B$1.62B$1.35B$1.89B
Income tax expense$433M$1.18B$306M$344M$411M
Net income$1.41B$3.2B$611M$411M$914M
Weighted average shares outstanding$90.2M$96.9M$101.6M$106.9M$106.8M
Weighted average diluted shares outstanding$90.8M$97.9M$104.8M$110.5M$108.6M
Balance sheet
20252024202320222021
Cash and short-term investments$2.88B$3.02B$1.23B$858M$2.36B
Net receivables$2.57B$3.05B$3.4B$3.46B$3.31B
Inventory$348M$346M$411M$405M$384M
Total current assets$7.85B$7.68B$7.17B$5.98B$7.08B
Property, plant and equipment, net$7.45B$7.09B$7.32B$7.59B$7.43B
Goodwill and intangible assets$12.5B$12.1B$11.7B$11.5B$10.8B
Long-term investments$1.44B$1.81B$1.89B$1.83B$2.03B
Total non-current assets$21.8B$21.3B$21.1B$21.2B$20.5B
Total assets$29.7B$28.9B$28.3B$27.2B$27.6B
Accounts payable$1.36B$1.29B$1.41B$1.5B$1.3B
Short-term debt$79M$296M$120M$145M$135M
Deferred revenue$0.00$0.00$0.00$110M$959M
Total current liabilities$4.46B$4.31B$4.76B$4.48B$5.11B
Long-term debt$13.1B$14B$14.9B$14.9B$15.5B
Deferred revenue, non-current$0.00$13M$0.00$13M$15M
Total non-current liabilities$16.2B$16.1B$18B$18.1B$18.2B
Capital lease obligations$0.00$1.34B$0.00$0.00$0.00
Total liabilities$20.7B$20.4B$22.8B$22.5B$23.3B
Common stock$8M$8M$8M$8M$8M
Retained earnings$4.42B$3.01B-$-192M-$-803M-$-1.21B
Accumulated other comprehensive income (loss)-$-181M-$-180M-$-181M-$-181M-$-233M
Total equity$8.97B$8.55B$5.51B$4.61B$4.26B
Total investments$1.44B$1.81B$1.89B$1.83B$2.03B
Total debt$13.2B$14.3B$15B$15.1B$15.6B
Net debt$10.3B$11.3B$13.8B$14.2B$13.3B
Cash flow statement
20252024202320222021
Net income$1.41B$4.06B$1.31B$1B$1.48B
Depreciation and amortization$886M$818M$870M$841M$855M
Stock-based compensation$104M$67M$66M$56M$56M
Change in working capital-$-44M$136M$71M-$-1.14B-$-737M
Accounts receivable$20M$245M-$-29M-$-140M-$-197M
Inventory-$-73M-$-86M-$-139M-$-64M-$-52M
Accounts payable$0.00-$-30M$215M-$-898M-$-584M
Net cash provided by operating activities$3.54B$2.05B$2.37B$1.08B$1.57B
Investments in property, plant and equipment-$-1.01B-$-931M-$-751M-$-762M-$-658M
Acquisitions, net-$-308M-$-571M-$-224M-$-234M-$-1.22B
Net cash used for investing activities-$-1.28B$3.43B-$-969M-$-808M-$-714M
Common stock issued$0.00$0.00$0.00$0.00$0.00
Common stock repurchased-$-1.44B-$-672M-$-200M-$-250M$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities-$-2.4B-$-3.69B-$-1.04B-$-1.78B-$-936M
Net change in cash-$-136M$1.79B$370M-$-1.51B-$-82M
Cash at end of period$2.88B$3.02B$1.23B$858M$2.36B
Operating cash flow$3.54B$2.05B$2.37B$1.08B$1.57B
Capital expenditure-$-1.01B-$-931M-$-751M-$-762M-$-658M
Free cash flow$2.53B$1.12B$1.62B$321M$910M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Tenet Healthcare Corporation

        Tenet Healthcare Corporation operates as a broad-ranging provider of health solutions. The company organizes its operations across three main divisions: Hospital Operations and Other, Ambulatory Care, and Conifer. Within its network of acute care facilities, Tenet delivers a full spectrum of essential services. These include core hospital functions such as operating and recovery suites, radiology and respiratory therapy, clinical laboratories, and on-site pharmacies. The organization also provides high-acuity patient care through intensive, critical, and coronary care units. Specialized medical services cover areas like cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics, alongside various outpatient treatments, including physical therapy. Advanced surgical capabilities feature cardiothoracic, complex spinal, and neurosurgery, as well as neonatal intensive care. Tenet extends its offerings to ultra-specialized quaternary care, exemplified by heart and kidney transplant programs, and sophisticated procedures such as limb-salvaging vascular interventions, acute Level 1 trauma care, intravascular stroke treatment, minimally invasive cardiac valve replacements, advanced imaging, and telemedicine access. Beyond its hospital network, Tenet manages numerous other clinical sites. These encompass outpatient surgical centers, immediate care facilities, diagnostic imaging centers, dedicated surgical hospitals, off-campus emergency departments, and micro-hospitals. Through its Conifer segment, the company furnishes critical healthcare business process solutions. These administrative services, offered to hospitals, health systems, physician practices, employers, and other clients, include financial administration for patient accounts (revenue cycle management), support for patient communications and engagement, and outcome-focused care strategies. As of February 9, 2022, Tenet's operational footprint included 60 hospitals and roughly 550 additional medical facilities. This count of additional sites comprises surgical hospitals, ambulatory surgery centers, urgent care and imaging centers, and various other clinical locations. Tenet Healthcare Corporation was established in 1975 and maintains its principal office in Dallas, Texas.

        CEO
        Saumya Sutaria
        Employees
        99K
        Beta
        1.27

        Included in

        Explore

        Frequently asked questions

        What is the intrinsic value of Tenet Healthcare Corporation (THC)?

        Tenet Healthcare Corporation (THC) is currently undervalued based on the InvestorsCraft IC model — IC value is 20–50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is THC undervalued?

        THC trades at a price of $263.19 (Nov 21, 2026): undervalued — IC value is 20–50% above the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.